KALA: KALA BIO, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 30.18
Enterprise Value ($M) 16.12
Book Value ($M) 6.86
Book Value / Share 1.49
Price / Book 4.40
NCAV ($M) 4.06
NCAV / Share 0.88
Price / NCAV 7.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.64
Return on Equity (ROE) -3.47

Liquidity (mrq)
Quick Ratio 2.15
Current Ratio 2.15

Balance Sheet (mrq) ($M)
Current Assets 51.28
Assets 54.08
Liabilities 47.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G ADAR1 Capital Management, LLC 9.99
07-08 13D Sr One Capital Management, Llc 9.99
06-28 13D Baker Bros. Advisors Lp 19.99 231.09
02-16 13G Millennium Management Llc 5.00
02-14 13G/A Checkpoint Capital L.P. 0.00 -100.00
01-29 13G/A Integrated Core Strategies (us) Llc 4.90 -0.77

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 6,103 83,838 7.28
2024-11-26 10,956 71,872 15.24
2024-11-25 2,271 17,955 12.65
2024-11-22 1,603 72,758 2.20

(click for more detail)

Similar Companies
ITRM – Iterum Therapeutics plc JAGX – Jaguar Health, Inc.
JSPR – Jasper Therapeutics, Inc. KPRX – Kiora Pharmaceuticals, Inc.
KRRO – Korro Bio, Inc.


Financial data and stock pages provided by
Fintel.io